Here are four highlights:
1. The company’s notes have a 3.65 percent annual interest rate.
2. Stryker’s offering is expected to settle March 7, subject to customary closing conditions.
3. Stryker plans to use the proceeds to repay $600 million of the company’s previous 1.30 percent notes due April 1.
4. Goldman Sachs & Co., Morgan Stanley and Wells Fargo are active joint book running managers for Stryker’s offering.
More articles on devices and implants:
Where Medtronic is headed: 5 quotes from the Q3 conference call
K2M, International Spine Study Group Foundation join forces for spine data collection – 5 things to know
Who’s leading the global spine surgery device market?
